HomeAI · summaries
Storia in 2 fonti
Outlook Shares Jump Following FDA Appeal Decision For LYTENAVA - Outlook Therapeutics (NASDAQ:OTLK)
Outlook Therapeutics Inc. shares are trading higher Tuesday after the FDA granted its appeal in the ONS-5010 dispute resolution process.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
Outlook Shares Jump Following FDA Appeal Decision For LYTENAVA - Outlook Therapeutics (NASDAQ:OTLK)
Outlook Therapeutics Inc. shares are trading higher Tuesday after the FDA granted its appeal in the ONS-5010 dispute resolution process.
- ·
fiercepharma.com
Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
Outlook Therapeutics has notched a win in its uphill battle to commercialize an ophthalmic version of Roche’s Avastin (bevacizumab) in the U.S., with the FDA now agreeing that the…